Label at a glance#

ProductGeri-kot

Active ingredientSENNOSIDES

Label structure8 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours

Dosage and administration

• do not exceed 8 tablets in 24 hours Age Starting Dose Maximum Dose adults and children 12 years of age and older 2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor 4 tablets in the morning and 4 tablets at bedtime children under 12 years ask a doctor

Storage and handling

each tablet contains: calcium 30 mg Tamper Evident: Do not use if imprinted seal under cap is missing or broken store at 20°C-25°C (68°F-77°F)

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Laxative

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)

generally produces bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

Do not use

for more than 1 week unless directed by a doctor.

Ask a doctor before use if you
• have abdominal pain, nausea or vomiting
• have noticed a sudden change in bowel habits that lasts over 2 weeks
Stop use and ask a doctor if

you have rectal bleeding
or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• do not exceed 8 tablets in 24 hours

Age	Starting Dose	Maximum Dose
adults and children 12 years of age and older	2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor	4 tablets in the morning and 4 tablets at bedtime
children under 12 years	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 30 mg
Tamper Evident: Do not use if imprinted seal under cap is missing or broken
store at 20°C-25°C (68°F-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, microcrystalline cellulose, silica, talc, triacetin

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
57896-415-01	EA - Each	57896-415	35474003-2d89-4f7c-8b19-f04514fdecb3	1	2023-05-05
57896-415-10	EA - Each	57896-415	c7308376-15ce-4e13-8ed0-5846bc0219d9	1	2023-04-07

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

Geri-kot
SENNOSIDES
CROSCARMELLOSE SODIUM
CELLULOSE, MICROCRYSTALLINE
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
SILICON DIOXIDE
MAGNESIUM STEARATE
TALC
TRIACETIN
HYPROMELLOSES

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
57896-415	57896-415-01, 57896-415-10, 57896-415-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
TALC	7SEV7J4R1U	IACT
TRIACETIN	XHX3C3X673	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
SENNOSIDES	3FYP5M0IJX	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
21f02bbe-f26b-9210-e063-6394a90a2ba5			f0e78c77-8896-5f2b-e053-2a95a90af2e8	2024-09-12	Warnings	Exact identifier spl id: 21f02bbe-f26b-9210-e063-6394a90a2ba5 spl set id: f0e78c77-8896-5f2b-e053-2a95a90af2e8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.